# CELL-REPORTS-D-21-02389R1
Analysis scripts and processed data for CELL-REPORTS-D-21-02389R3
Title: Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors
